The 13th Annual Business of Biosimilars & Generic Drugs event is taking place in 2 weeks! The following companies from over 10 countries around the world will be in attendance:
* Abbott Laboratories * Amgen Inc * Amneal Pharmaceuticals * AriVan Research LLC * Baxter Healthcare Corp * Biogen Idec * BioProcess International * Biotechnology Industry Organization * Boston Oncology * Bristol-Myers Squibb * Burrill & Co * Celltrion * Covance Laboratories Inc * Endo Pharmaceuticals Inc * Express Scripts * Federal Trade Commission * Gedeon Richter USA Inc * Greenblum & Bernstein PLC * HartmannWillner LLC * Harvest Moon Pharmaceuticals * Hoffmann-La Roche * Hospira, Inc. * Human Genome Sciences Inc * Janssen-Ortho Inc * Johnson & Johnson * Lathrop & Gage * Legasis Services * McAndrews Held & Malloy Ltd * Medac GmbH * Meiji Seika Pharma Co Ltd * Merck Serono SA * Momenta Pharmaceuticals Inc * Mylan Pharmaceuticals Inc * Nova Venture Fund Ltd * Novation, LLC * Par Pharmaceutical * Pharmac * Roxane Laboratories Inc * Sandoz Inc * Sawai Pharmaceutical * Shire * Sigmapharm Laboratories, LLC * STADA PharmDevelopment * STC Biologics Inc * Sutherland Asbill & Brennan * Teva Pharmaceuticals * Thomson Reuters * Valin Technologies * Wockhardt USA * Xencor Inc *
The 13th Annual Business of Biosimilars and Generic Drugs Event will take place September 10-12, 2012 in Boston, MA. As a reader of this blog, you receive an exclusive discount of 25% off of the standard rate when you register to join us. Simply use priority code XP1786BLOG. Have any questions about the event? Feel free to contact email jpereira@iirusa.com.
|
Share this article with your social network, just click below to share now!
|
|
|
No comments :
Post a Comment